Pacific Biosciences
PACB
#6534
Rank
S$0.78 B
Marketcap
$2.66
Share price
-3.90%
Change (1 day)
-78.30%
Change (1 year)

Pacific Biosciences (PACB) - Cash on Hand

Cash on Hand as of September 2024 : S$0.63 Billion

According to Pacific Biosciences 's latest financial reports the company has S$0.63 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Pacific Biosciences - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.83 B-19.46%
2022-12-31S$1.03 B-26.67%
2021-12-31S$1.41 B234.76%
2020-12-31S$0.42 B537.17%
2019-12-31S$66.19 M-52.66%
2018-12-31S$0.13 B66.28%
2017-12-31S$84.09 M-19.28%
2016-12-31S$0.10 B-10.48%
2015-12-31S$0.11 B-13.1%
2014-12-31S$0.13 B-6.07%
2013-12-31S$0.14 B15.91%
2012-12-31S$0.12 B-46.47%
2011-12-31S$0.22 B-37.11%
2010-12-31S$0.36 B180.67%
2009-12-31S$0.13 B-14.16%
2008-12-31S$0.15 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.26 B 99.30%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.13 B-79.39%๐Ÿ‡บ๐Ÿ‡ธ USA
S$21.53 B 3,286.63%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.96 B 1,310.39%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.32 B 422.37%๐Ÿ‡บ๐Ÿ‡ธ USA